Johnson & Johnson Results Driven by Pharmaceutical Sales Growth

Johnson & Johnson reported an increase in sales for its fourth quarter, largely spurred by its pharmaceutical business, but reported a loss because of effects from the new tax law.

from WSJ.com: US Business http://ift.tt/2n33MKp
via IFTTT